HR-7601-119
Referred to the House Committee on the Judiciary.
Sponsored by Thomas Massie (R-KY)
What it does
This bill would do two things. First, it would prohibit the use of any federal funds to implement, administer, or enforce a February 2026 Executive Order directing the government to ensure an adequate supply of elemental phosphorus and glyphosate-based herbicides. Second, it would create a federal civil cause of action allowing anyone harmed by exposure to elemental phosphorus or glyphosate-based herbicides to sue manufacturers, distributors, and sellers in federal court — and would explicitly strip those companies of any immunity or legal defenses they might otherwise claim under the Defense Production Act or related federal contractor protections.
Who benefits
People who have suffered or may suffer physical injury, illness, or death from exposure to glyphosate or elemental phosphorus, including agricultural workers, farmworkers, landscapers, and residents near treated areas. Plaintiffs' attorneys who would gain a new federal litigation avenue with fee-shifting provisions. State courts and litigants with pending claims, whose cases would be preserved and potentially strengthened. Competing herbicide manufacturers who do not produce glyphosate-based products. Environmental and public health advocacy organizations that have sought accountability for glyphosate exposure.
Who is hurt
Glyphosate manufacturers — most prominently Bayer/Monsanto, which faces tens of thousands of existing Roundup lawsuits — would lose federal immunity defenses and face expanded federal liability. Distributors, formulators, and retailers of glyphosate products would also be exposed to new litigation. Farmers and agricultural operations that rely on glyphosate-based herbicides as a cost-effective tool could face supply disruptions or price increases if manufacturers scale back production in response to liability exposure. The federal government agencies tasked with implementing the Executive Order would lose funding authority. Defense and national security planners who view domestic glyphosate and phosphorus supply as a strategic priority could see those goals undermined.
Supporters argue
Supporters argue that the Executive Order effectively grants manufacturers a liability shield at taxpayers' expense, insulating companies from accountability for health harms that courts and juries have already found credible — Bayer has paid over $10 billion in glyphosate settlements. They contend that no corporation conducting commercial activity should be able to invoke a national defense order to escape civil liability for personal injury, and that the Defense Production Act was never intended to immunize private companies from tort claims brought by injured individuals. They further argue that Congress, not the Executive Branch, holds the constitutional authority to grant or remove legal immunities.
Opponents argue
Opponents argue that the Executive Order reflects a legitimate national security determination that domestic glyphosate and phosphorus supplies are critical to U.S. agricultural and defense capacity, and that stripping liability protections from compliant manufacturers will deter production, undermine supply chain resilience, and harm American farmers who depend on affordable herbicides. They contend that existing state tort systems already provide injured parties with remedies, and that creating a new, unlimited federal cause of action — with no statute of limitations specified and retroactive application — exposes manufacturers to potentially ruinous litigation that goes far beyond compensating actual harm.
Constitutional context
Congress has broad authority under the Commerce Clause (Art. I, §8, cl. 3) to create federal causes of action for products sold in interstate commerce and to restrict the use of appropriated funds. The bill's retroactive application of liability and nullification of existing legal defenses could raise Due Process concerns under the Fifth Amendment, though Congress has historically been permitted to modify prospective tort liability frameworks. Post-Loper Bright (2024), courts would independently assess whether the Executive Order's claimed authority under the Defense Production Act actually supports the immunity the bill seeks to remove.
Checks and balances
Congress would gain authority by defunding an Executive Order and overriding executive-branch-granted liability protections; the check on this power is judicial review of the new federal cause of action, including potential constitutional challenges by manufacturers to retroactive liability and the elimination of established legal defenses.
Historical precedent
The PREP Act (2005) similarly granted liability immunity to manufacturers of medical countermeasures under federal emergency declarations, and Congress has periodically debated whether such shields are appropriate — though no direct federal analogue stripping Defense Production Act immunity for a specific commercial product class has previously been enacted.